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Differential infiltration of neutrophils 
in T1–T2 versus T3–T4 oral squamous cell 
carcinomas: a preliminary study
Patrícia Carlos Caldeira1*, Alexandre de Andrade Sousa2 and Maria Cássia Ferreira de Aguiar1
Abstract 
Background: Recent studies have pointed towards a role of tumour-infiltrating neutrophils in cancer biology. Investi-
gations on oral squamous cell carcinoma have indicated a possible association with clinical characteristics. This study 
aimed to evaluate neutrophil infiltration and the neutrophil/lymphocyte ratio in the central areas and invasive front of 
oral squamous cell carcinomas at different T stages, and their association with clinicopathological features and patient 
outcome.
Methods: Clinical information was retrieved from the charts of patients who had undergone surgical treatment. 
Samples of the excised tumours were subjected to immunohistochemical analysis for CD66b and CD3. Semi-quanti-
tative analysis was performed in the intratumoural region and in the invasive front. Appropriate statistical tests were 
used for evaluating the data, including Kaplan–Meier survival analysis and the log-rank test. A p value of less than 0.05 
was considered significant.
Results: T3–T4 tumours presented higher CD66b infiltration in the intratumoural region and higher CD66b/CD3 
ratios in the invasive front than T1–T2 lesions (p < 0.05). There was a strong inverse correlation between CD66b and 
CD3 in the invasive front of T3–T4 tumours (r = −0.712, p < 0.05). Comparisons of CD66b and the CD66b/CD3 ratio 
according to N status, tumour location, recurrence, inflammation grade, and histological grade did not reach statisti-
cal significance. Survival analysis also did not show any significant differences.
Conclusions: The present study showed different degrees of neutrophil infiltration between T1–T2 and T3–T4 oral 
cancers, with higher indexes in the advanced lesions. However, there was no association with clinicopathological 
features or with time to recurrence.
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Background
Squamous cell carcinoma (SCC) is the most frequent 
cancer of the oral cavity, affecting mainly elderly men 
with a smoking habit. Despite therapeutic advances, the 
overall estimated 5-year survival is 56  % [1]. Currently, 
the TNM system is used as the prognostic indicator for 
SCC patients, but its performance is suboptimal in some 
cases [2].
Evidence points towards a role of tumour-associated 
leucocytes in the development and progression of malig-
nant neoplasms, as these cells may exert stimulatory and 
inhibitory functions in the microtumour milieu [3–5]. 
Despite being previously neglected, neutrophils have 
now arisen as an important leucocyte in cancer biology, 
with pro- and anti-tumour functions [3, 5–12].
Tumour-associated neutrophils (TANs) may be 
detected in the intratumour, peritumour, or tumour-
surrounding regions, and some studies have reported a 
clinical relevance of neutrophil infiltration in diverse can-
cers [12–17]. In a recently published review on this topic, 
Donskov et  al. [18] reported the prognostic value of a 
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high neutrophil count and neutrophil/lymphocyte ratio 
(NLR).
In head and neck carcinoma, T4 tumours presented 
higher neutrophil infiltration than T1 and T2 types [19]. 
Patients staged as III and IV with low amounts of TANs 
had a better 5-year survival than those with high neutro-
phil infiltration [19].
Some studies have exploited the participation and 
clinical relevance of TANs in oral SCC. A high NLR 
was associated with poor prognosis [12, 20, 21], poor 
tumour differentiation [20], and higher clinical stages 
[12, 22]. Moreover, a high neutrophil density was associ-
ated with lymph node metastasis and recurrence [12] and 
poor differentiation [21]. On the other hand, these stud-
ies reported a lack of association between TANs and age 
[12, 20, 21], tumour location [21], tumour size [12, 21], N 
stage [21], tumour grade [12], and clinical stage [20].
Considering the relevant role of neutrophils within 
the tumoural environment and the emerging results on 
TANs and oral SCC, we aimed to evaluate the neutrophil 
infiltration and NLR in oral SCCs at different T stages. 
Taking into account the intratumoural heterogeneity, 
neutrophils and lymphocytes were evaluated in the cen-
tral areas and invasive front of the tumours. Additionally, 
we explored the possible association of these indexes with 
tumour grade, clinical features, and patient outcome.
Methods
Samples
The study was approved by the Committee of Ethics in 
Research of the Universidade Federal de Minas Gerais 
(28773114.7.0000.5149). Patients attending the Head and 
Neck Surgery Ambulatory Department gave written con-
sent for the use of their registered data and tumour speci-
mens in research developed at the Universidade Federal 
de Minas Gerais.
The files of the Head and Neck Surgery Department of 
the Hospital das Clínicas of the Universidade Federal de 
Minas Gerais were reviewed. Cases of patients who had 
undergone surgical treatment for oral SCC were selected, 
and clinical information was retrieved from the charts. 
Collected data included age, sex, smoking habit, alcohol 
consumption, lesion location, surgical treatment, radio-
therapy, N stage, and follow-up.
The tumour specimens of these patients were retrieved 
from the files of the Laboratory of Pathological Anat-
omy of the same hospital. Paraffin blocks containing the 
invasive front region were used for tumour grading and 
immunohistochemical analysis.
Histopathological grading of tumours
Slide samples stained with haematoxylin and eosin were 
independently reviewed by two oral pathologists (P.C.C. 
and M.C.F.A.), who graded the lesions according to the 
criteria established by Bryne et  al. [23]. Discrepancies 
were resolved via discussion of the cases. At this point in 
the study, the pathologists were unaware of the T stage of 
the lesions.
Inflammation grading
The amount of inflammatory infiltrate present in each 
slide (irrespective of cell type or immunostaining) was 
graded according to Bryne et  al. [23] criteria as absent, 
weak, moderate, or intense.
Immunohistochemistry
Tissues were subjected to immunohistochemical anal-
ysis for CD66b (1:600, clone GF10F5; BD Biosciences, 
EUA, code 555723) and CD3 (1:200, clone F7.2.38; 
Dako Cytomation, Denmark, code M7254). Sections 
were deparaffinised in xylol and hydrated in an etha-
nol solution. Antigen retrieval was performed with a 
TRIS–EDTA solution (pH 9.0) in a 96  °C water bath 
for 30  min. The hydrogen peroxide blocking, protein 
blocking, and detection steps were performed with 
ready-to-use solutions provided in the kit (Spring 
BioScience, SPB-999). The reaction was revealed with 
3,3′-diaminobenzidine (Spring BioScience, code DAB-
999), and haematoxylin was used for the counterstain-
ing. Appropriate positive and negative controls were 
included.
Evaluation of immunohistochemistry
One observer (P.C.C.) evaluated all cases using an optical 
microscope (Zeiss Axiostar Ser. 48824). A semi-quantita-
tive analysis was done, based on the reports by Lundqvist 
et  al. [24] and Shinriki et  al. [21]. CD66b+ cells located 
inside blood vessels were not considered for quantifica-
tion. Five high-power fields (400× magnification) were 
analysed separately in the invasive front and in the intra-
tumoural region (Additional files 1, 2), and positivity was 
graded as 0 (no staining), 1 (1–25 % of positive cells), 2 
(25–50 %), and 3 (>50 %). The mean value of the scores 
from the five fields was set as the CD66b and CD3 index 
of staining for each case. The CD66b/CD3 ratio was 
obtained by dividing the CD66b and CD3 indexes of each 
slide.
Statistical analysis
Statistical tests were performed using SPSS® version 
19.0 for Windows and GraphPad Prism® version 6.0 for 
Windows.
Firstly, the Shapiro–Wilk normality test was applied. 
Comparisons of clinical and microscopic features 
between the T1–T2 and T3–T4 groups were performed 
with the Pearson χ2 test.
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The t test was used for comparisons of the CD66b and 
CD3 indexes between the T1–T2 and T3–T4 groups. 
The Spearman test was used to analyse the correlation 
between the CD66b and CD3 indexes.
Kruskal–Wallis and Mann–Whitney tests were used to 
compared the CD66b staining indexes and the CD66b/
CD3 ratio between cases grouped according to N sta-
tus (positive vs. negative), tumour location (tongue vs. 
floor of the mouth), recurrence (yes vs. no), inflamma-
tion grade [from Bryne classification: grade 1 (intense), 2 
(moderate), 3 (weak)], and histological grade (from Bryne 
classification: I, II, III).
For the survival analysis, recurrence was the event 
of interest. Thus, the Kaplan–Meier method was used 
to evaluate patients grouped according to T stage (T1–
T2 vs. T3–T4), CD66b index, and CD66b/CD3 ratio 
(the latter 2 being classified into low vs. high, accord-
ing to median values). The log-rank test was used for 
comparisons.
For all the tests described above, a p value of less than 
0.05 was considered significant.
Results
Twenty-eight patients were included in the study. They 
were mainly males (n =  20, 71.4  %) above 50  years of age 
(n =  21, 75.0 %). Smoking habit (current or previous) was 
reported by most individuals (n = 25, 89.3 %), as well as alco-
hol consumption (n = 23, 82.1 %). Lesions were located in 
the tongue (n = 13, 46.4 %) or floor of the mouth (n = 15, 
53.6 %). Lymph node involvement was observed in nine cases 
(32.1 %). With regard to treatment modality, tumour resec-
tion and unilateral neck dissection were performed in most 
cases (n = 15, 53.6 %), and adjuvant radiotherapy was used 
in 15 patients (53.6 %). The mean follow-up was 29 months 
(range 1–92 months) and 9 tumours recurred (32.1 %).
Most lesions were histologically classified as grade II 
(n =  21, 75.0 %). Inflammatory infiltrate was present in 
all cases and graded as intense in 10 cases (35.7 %), mod-
erate in 12 (42.9 %), and weak in 6 (21.4 %).
Furthermore, cases were grouped according to T stages 
for comparisons. The detailed clinical and histopatholog-
ical data are presented in Table 1. One group comprised 
13 patients (46.4 %) with T1 and T2 tumours, whereas the 
other group was composed of 15 patients with T3 and T4 
tumours (53.6 %). Surgical treatment, adjuvant radiother-
apy, and lymph node involvement differed between the 2 
groups (p < 0.05, Pearson χ2 test; Table 1). Patients with 
T1–T2 lesions were usually treated with tumour resec-
tion, unilateral neck dissection, and without adjuvant 
radiotherapy, whereas tumour resection, bilateral neck 
dissection, and radiotherapy were performed for T3–T4 
lesions. Accordingly, lymph node involvement was rare in 
T1–T2 tumours, but not in T3–T4.
With regard to the immunostaining, CD66b+ cells 
were detected in all but 1 case (Additional file 1), whereas 
CD3+ lymphocytes were invariably present (Additional 
file  2). The immunostaining results can be observed in 
Fig. 1.
Statistical comparisons of the immunostaining indexes 
showed that the T3–T4 tumours presented higher 
Table 1 Clinical and  microscopic characteristics of  the 
patients with oral squamous cell carcinoma
* Calculated with valid cases only; ** statistically significant
T1–T2 (%) T3–T4 (%) Pearson χ2*
Age 0.535
 <50 years 2 (15.4) 4 (26.7)
 ≥50 years 10 (76.9) 11 (73.3)
 Data not available 1 (7.7) –
Sex 0.281
 Male 8 (61.5) 12 (80.0)
 Female 5 (38.5) 3 (20.0)
Smoking habit 0.292
 Yes 4 (30.8) 9 (60.0)
 No 2 (15.4) 1 (6.7)
 Previous 7 (53.8) 5 (33.3)
Alcohol consumption 0.796
 Yes 5 (38.5) 4 (26.7)
 No 2 (15.4) 3 (20.0)
 Previous 6 (46.1) 8 (53.3)
Lesion location 0.136
 Tongue 8 (61.5) 5 (33.3)
 Floor of the mouth 5 (38.5) 10 (66.7)
Surgical treatment 0.016**
 Tumour resection 2 (15.4) 1 (6.7)
 Tumour resection and unilateral 
neck dissection
10 (76.9) 5 (33.3)
 Tumour resection and bilateral 
neck dissection
1 (7.7) 9 (60.0)
Adjuvant radiotherapy 0.000**
 Yes 1 (7.7) 14 (93.3)
 No 11 (84.6) 1 (6.7)
 Data not available 1 (7.7) –
Lymph node involvement 0.010**
 Yes 1 (7.7) 8 (53.3)
 No 12 (92.3) 7 (46.7)
Recurrence 0.149
 Yes 5 (38.5) 4 (26.7)
 No 6 (46.1) 11 (73.3)
 Data not available 2 (15.4) –
Bryne classification 0.635
 Grade I (4–8) 3 (23.1) 3 (20.0)
 Grade II (9–12) 10 (76.9) 11 (73.3)
 Grade III (13–16) 0 1 (6.7)
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CD66b+ indexes in the intratumoural region and higher 
CD66b/CD3 ratios in the invasive front than did the T1–
T2 lesions (p < 0.05, t test; Table 2; Fig. 2). Additionally, 
there was a strong and an inverse correlation between the 
CD66b and CD3 infiltration indexes in the invasive front 
of the T3–T4 tumours (r = −0.712, p < 0.05, Spearman 
test; Fig. 2).
Comparisons of the CD66b infiltration index and 
CD66b/CD3 ratio according to N status, tumour loca-
tion, recurrence, inflammation grade, and histologi-
cal grade did not reach statistical significance (p > 0.05, 
Kruskal–Wallis and Mann–Whitney tests).
The time to recurrence was evaluated in the survival 
analysis, where comparisons were performed as follows 
Fig. 1 Tongue squamous cell carcinoma. Immunohistochemical detection of CD66b+ neutrophils in the invasive front (a) and intratumoural region 
(b) and CD3+ lymphocytes in the invasive front (c) and intratumoural region (d). Original magnification: a, c = ×100; b, d = ×200
Table 2 CD66b infiltration index and  CD66b/CD3 ratio 
in T1–T2 versus T3–T4 tumours
Results are shown as mean values ± standard deviation; p values refer to the t 
test; * statistically significant
Invasive front Intratumoural region
CD66b infiltration index
 T1–T2 0.86 ± 0.56 0.41 ± 0.38
 T3–T4 1.33 ± 0.89 1.17 ± 1.03
 p value 0.101 0.015*
CD66b/CD3 ratio
 T1–T2 0.36 ± 0.28 0.31 ± 0.27
 T3–T4 0.85 ± 0.79 0.61 ± 0.57
 p value 0.034* 0.084
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(Table 3; Fig. 3): T1–T2 vs. T3–T4 lesions, high vs. low 
CD66b index in the invasive front; high vs. low CD66b 
index in the intratumoural region; high vs. low CD66b/
CD3 ratio in the invasive front; and high vs. low CD66b/
CD3 ratio in the intratumoural region. For all these com-
parisons, there were no statistically significant differences 
(p > 0.05, log-rank test; Table 3; Fig. 3).
Discussion
In the present study, advanced oral SCCs presented a 
higher infiltration of TANs within the intratumoural 
region than did initial lesions. Similarly, Trellakis et  al. 
[19] reported that advanced head and neck SCCs were 
infiltrated by neutrophils, and T4 lesions showed higher 
infiltration than T1–T3 tumours. Wang et  al. [12] also 
identified intratumoural CD15+ neutrophils in tongue 
SCCs.
The presence of neutrophils within the intratumoural 
area may be related to their functions within cancer biol-
ogy (Fig.  2) [25]. The cross-talk between neutrophils 
and cancer cells may be related to cancer cell motility 
[26], migratory activity [27], cytoskeletal changes [28], 
and tumour cell proliferation [28, 29]. In turn, cancer 
cells may have feedback effects on neutrophils, increas-
ing their migration and survival, or leading to a different 
activation status [19, 25, 26, 28, 30]. Further investigation 
on the molecules and pathways involved in the cross-talk 
between cancer cells and neutrophils may clarify the par-
ticipation of TANs in oral SCC pathogenesis.
Recent studies have encompassed the role of myeloid-
derived suppressor cells (MDSCs) in cancer [31–33]. 
MDSCs comprise a heterogeneous cell population 
with immunosuppressor function, for which there is 
no specific marker (or even a defined and exclusive 
Fig. 2 The differential infiltration of neutrophils in T3–T4 oral squamous cell carcinomas in the intratumoural region and invasive front found in the 
present study may be related to their diverse functions within the tumoural microenvironment, interacting with cancer cells, lymphocytes, and the 
extracellular matrix (see the “Discussion” section for further information)
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panel of markers) [31–33]. One subset of MDSCs, the 
granulocytic MDSCs, shares overlapping features with 
neutrophils with regard to cell morphology (polymor-
phonuclear granulocytic cells), phenotype (both are 
CD15 and CD66b positive), and function (e.g. arginase-1 
and myeloperoxidase production) [33]. Although the 
immunosuppressive activity is regarded as a hallmark of 
granulocytic MDSCs, neutrophils may also exert immu-
nosuppressive activity if activated [31, 33]. Therefore, 
distinguishing between neutrophils and granulocytic 
MDSCs may be broadly difficult [33]. Accordingly, some 
cells named “neutrophils” in the present study could rea-
sonably represent MDSCs instead. In any case, as stated 
by Brandau et al. [33], tumour-associated neutrophils and 
granulocytic MDSCs guard close resemblances to each 
other and may ‘represent similar functional states of cells 
originating from the same cell type’.
Tumours should be regarded as heterogeneous masses 
[34], and the invasive front is considered the most aggres-
sive area [35]. In the present study, there was a higher 
NLR in the invasive front of T3–T4 tumours, and an 
inverse correlation between neutrophils and T lym-
phocytes was detected (Fig. 2). Likewise, Tsai et al. [22] 
showed a decrease in lymphocytes and an increase in 
neutrophil counts with the advancement of clinical stage 
of oral SCCs. Neutrophils may influence the recruit-
ment and function of CD8+ and CD4+ T lymphocytes, 
both important cells in the cancer microenvironment. 
Besides this, T lymphocytes can modulate neutrophil 
function [28, 36–41]. Neutrophils can also contribute 
to matrix re-modelling and angiogenesis in the invasive 
front, favouring cancer spread [13, 25, 42–44]. Interest-
ingly, it has been shown that neutrophils can be recruited 
to niches of distant metastasis and may participate in the 
metastatic spread of cancer [45].
In the present study, we failed to find any associa-
tion between neutrophils and clinicopathological fea-
tures, including in the survival analysis. Previous studies 
reported associations with poor prognosis [12, 20, 21], 
poor tumour differentiation [21], higher clinical stages 
[12, 22], lymph node metastasis, and recurrence [12]. 
However, these observations are not unanimous in the 
literature [12, 20, 21]. Concerning these discrepancies, 
some points merit a few comments. Firstly, certain stud-
ies employed tissue microarrays, in which a limited area 
of the lesion was evaluated. In the present study, how-
ever, we evaluated the tumour as a whole. Importantly, 
we report differences in results between distinct tumour 
areas. Secondly, as a preliminary study, the limited num-
ber of cases included herein may have interfered with 
the results and statistical analysis, and further investiga-
tions are encouraged. Thirdly, the non-standardisation of 
immunohistochemical evaluation methods continues to 
pose challenges when comparing study results. Although 
quantitative, semi-quantitative, and computer-based 
analyses are suitable, all of them clearly have advantages 
and limitations.
Conclusion
The present study showed different degrees of neutro-
phil infiltration between T1–T2 and T3–T4 oral SCCs, 
with higher indexes in the advanced lesions. There was 
Table 3 Survival analyses
* Survival analysis was performed using the Kaplan–Meier method and log-rank test
Number of cases Months of follow-up  
(mean)
Number of events  
(recurrences)




 T1–T2 13 22.0 5 20.6
 T3–T4 15 29.8 4 19.3
CD66b index in invasive front 0.691
 High 13 24.5 4 12.5
 Low 15 35.6 5 26.0
CD66b index in intratumoural region 0.879
 High 14 30.3 4 18.8
 Low 14 28.1 5 21.0
CD66b/CD3 ratio in invasive front 0.600
 High 14 22.2 4 10.3
 Low 14 36.2 5 27.8
CD66b/CD3 ratio in intratumoural region 0.757
 High 14 24.8 3 13.7
 Low 14 33.6 6 23.2
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no association with clinicopathological features or 
with time to recurrence. Knowledge on the clinical and 
pathological importance of TANs, especially in oral 
SCC, is starting to be built. Results reported to date are 
exciting and encourage further studies to explore the 
neutrophil-derived molecules present in tumours.
Additional files
Additional file 1. Detailed scores of immunohistochemical evaluation 
of CD66b. This table reports the scores obtained for each slide field in all 
samples for the immunohistochemical evaluation of CD66b.
Additional file 2. Detailed scores of immunohistochemical evaluation 
of CD3. This table reports the scores obtained for each slide field in all 
samples for the immunohistochemical evaluation of CD3.
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